This document discusses validation of analytical procedures for drug substances and products. It describes key validation characteristics including specificity, accuracy, precision (repeatability and intermediate precision), detection limit, quantitation limit, linearity, range, and robustness. Validation is required for identification tests, assays of active ingredients and selected components, and tests for impurities. The level of validation depends on the objective and type of analytical procedure.
This document provides an overview of analytical method validation. It discusses key validation characteristics such as specificity, linearity, range, accuracy, precision, LOD and LOQ. Guidelines for validation from organizations like ICH, USP, ANVISA and AOAC are also mentioned. The document describes procedures for establishing various validation parameters and evaluating the results. It emphasizes that validation is necessary to ensure analytical methods consistently provide reliable results.
Analytical Method Validation basics by Dr. A. AmsavelDr. Amsavel A
This document discusses analytical method validation which is the process of confirming that an analytical method is suitable for its intended purpose. Key aspects of method validation discussed include accuracy, precision, specificity, linearity, range, detection limit, quantitation limit, repeatability and intermediate precision. The document outlines validation parameters for different types of analytical methods and provides examples of acceptance criteria. It also discusses guidance from regulatory agencies on analytical method validation.
Analytical method validation, ICH Q2 guidelineAbhishek Soni
Analytical Method Validation, ICH Q2 Guideline.
General principles related to the analytical method validation.
Validation of analytical method as per International Council for Harmonisation(ICH) guidelines and the United States Pharmacopeia(USP).
Glossary.
Useful in understanding the terms :
Specificity
Linearity
Range
Accuracy
Precision
Detection limit
Quantitation limit
Robustness
Ruggedness
System suitability testing
The document discusses analytical method validation, including defining method validation as ensuring an analytical method provides acceptable data for its intended use. It outlines the common steps in method development and validation and the validation parameters that should be assessed, including accuracy, precision, specificity, linearity, range, and robustness. The document provides details on how each of these parameters should be evaluated during the validation process.
This document discusses validation in the pharmaceutical industry. It begins by defining validation as establishing evidence that a process maintains compliance. It then discusses why validation is important, including that regulatory agencies require validation to ensure consistent, reproducible results. It outlines the types of validation including equipment, facilities, analytical methods, and more. It focuses on analytical method validation, discussing parameters like accuracy, precision, specificity, and more. It emphasizes that validation is necessary to confirm analytical procedures consistently produce the intended results.
The document discusses analytical method validation. It defines validation as establishing evidence that a process will consistently produce a product meeting predetermined specifications. The objectives are to discuss aspects of validation including principles, approaches, and characteristics. Key steps in validation are establishing accuracy, precision, specificity, linearity, range, limits of detection and quantification, and robustness of analytical procedures used for identification, quantification of impurities and active ingredients.
Analytical method validation as per ich and usp shreyas B R
Analytical method validation is a process of documenting/ proving that an analytical method provides analytical data acceptable for the intended use.After the development of an analytical procedure, it is must important to assure that the procedure will consistently produce the intended a precise result with high degree of accuracy. The method should give a specific result that may not be affected by external matters. This creates a requirement to validate the analytical procedures. The validation procedures consists of some characteristics parameters that makes the method acceptable with addition of statistical tools.
This document provides a summary of analytical method validation. It discusses the types of analytical procedures that should be validated, including identification tests, quantitative impurity tests, limit tests, and active moiety assays. It also summarizes key validation characteristics that should be considered, such as accuracy, precision, specificity, range, detection limit, quantitation limit, linearity, and robustness. The document provides definitions and methodology recommendations for validating analytical procedures. It emphasizes that the validation process verifies that an analytical method is suitable for its intended purpose.
This document provides an overview of analytical method validation. It discusses key validation characteristics such as specificity, linearity, range, accuracy, precision, LOD and LOQ. Guidelines for validation from organizations like ICH, USP, ANVISA and AOAC are also mentioned. The document describes procedures for establishing various validation parameters and evaluating the results. It emphasizes that validation is necessary to ensure analytical methods consistently provide reliable results.
Analytical Method Validation basics by Dr. A. AmsavelDr. Amsavel A
This document discusses analytical method validation which is the process of confirming that an analytical method is suitable for its intended purpose. Key aspects of method validation discussed include accuracy, precision, specificity, linearity, range, detection limit, quantitation limit, repeatability and intermediate precision. The document outlines validation parameters for different types of analytical methods and provides examples of acceptance criteria. It also discusses guidance from regulatory agencies on analytical method validation.
Analytical method validation, ICH Q2 guidelineAbhishek Soni
Analytical Method Validation, ICH Q2 Guideline.
General principles related to the analytical method validation.
Validation of analytical method as per International Council for Harmonisation(ICH) guidelines and the United States Pharmacopeia(USP).
Glossary.
Useful in understanding the terms :
Specificity
Linearity
Range
Accuracy
Precision
Detection limit
Quantitation limit
Robustness
Ruggedness
System suitability testing
The document discusses analytical method validation, including defining method validation as ensuring an analytical method provides acceptable data for its intended use. It outlines the common steps in method development and validation and the validation parameters that should be assessed, including accuracy, precision, specificity, linearity, range, and robustness. The document provides details on how each of these parameters should be evaluated during the validation process.
This document discusses validation in the pharmaceutical industry. It begins by defining validation as establishing evidence that a process maintains compliance. It then discusses why validation is important, including that regulatory agencies require validation to ensure consistent, reproducible results. It outlines the types of validation including equipment, facilities, analytical methods, and more. It focuses on analytical method validation, discussing parameters like accuracy, precision, specificity, and more. It emphasizes that validation is necessary to confirm analytical procedures consistently produce the intended results.
The document discusses analytical method validation. It defines validation as establishing evidence that a process will consistently produce a product meeting predetermined specifications. The objectives are to discuss aspects of validation including principles, approaches, and characteristics. Key steps in validation are establishing accuracy, precision, specificity, linearity, range, limits of detection and quantification, and robustness of analytical procedures used for identification, quantification of impurities and active ingredients.
Analytical method validation as per ich and usp shreyas B R
Analytical method validation is a process of documenting/ proving that an analytical method provides analytical data acceptable for the intended use.After the development of an analytical procedure, it is must important to assure that the procedure will consistently produce the intended a precise result with high degree of accuracy. The method should give a specific result that may not be affected by external matters. This creates a requirement to validate the analytical procedures. The validation procedures consists of some characteristics parameters that makes the method acceptable with addition of statistical tools.
This document provides a summary of analytical method validation. It discusses the types of analytical procedures that should be validated, including identification tests, quantitative impurity tests, limit tests, and active moiety assays. It also summarizes key validation characteristics that should be considered, such as accuracy, precision, specificity, range, detection limit, quantitation limit, linearity, and robustness. The document provides definitions and methodology recommendations for validating analytical procedures. It emphasizes that the validation process verifies that an analytical method is suitable for its intended purpose.
Analytical methods validation as per ich & uspGANESH NIGADE
This document discusses analytical method validation as per ICH and USP guidelines. It defines validation as establishing documentary evidence that a procedure maintains compliance. Method validation involves demonstrating that an analytical procedure is suitable for its intended purpose by testing parameters such as accuracy, precision, specificity, detection limit, quantitation limit, linearity, range, ruggedness and robustness. It also discusses the different types of analytical procedures that require validation including identification tests, quantitative impurity tests, limit tests and assays.
analytical method validation and validation of hplcvenkatesh thota
The document summarizes a seminar on analytical method validation and validation of HPLC. It discusses parameters for method validation according to USP, BP, and ICH guidelines such as accuracy, precision, linearity, range, specificity, detection limit, and quantitation limit. It also covers validation of typical HPLC systems through qualification, design, installation, operational, and performance qualification. Key parameters evaluated during HPLC method validation are discussed, including system suitability tests involving retention factor, relative retention, theoretical plates, resolution, and tailing factor.
This document discusses validation and calibration of HPLC systems. It defines validation as establishing that an analytical procedure meets requirements for its intended use through laboratory studies. A validation protocol outlines how validation will be conducted. Equipment validation demonstrates that equipment is suitable for use and comparable to routine equipment. Calibration involves demonstrating that an instrument produces results within specified limits compared to a reference standard. The document outlines parameters to validate like accuracy, precision, specificity, range, robustness and more. It provides details on testing these parameters and accepting calibration of modules like the pump, injector, detector and column heating.
University Institute of Pharmaceutical Sciences is a flag bearer of excellence in Pharmaceutical education and research in the country. Here is another initiative to make study material available to everyone worldwide. Based on the new PCI guidelines and syllabus here we have a presentation dealing with qualifications of HPLC which is the " High Performance Liquid Chromatography".
Thank you for reading.
Hope it was of help to you.
UIPS,PU team
This document discusses the key aspects of analytical method validation including specificity, linearity, range, accuracy, precision, detection limit, quantitation limit, robustness, and system suitability testing. It provides detailed descriptions and recommendations for establishing each validation characteristic to demonstrate that an analytical procedure is suitable for its intended use.
This document outlines guidelines for analytical method validation as described in ICH Q2. It defines validation as establishing evidence that a method is suitable for its intended purpose. Key parameters that must be validated include accuracy, precision, specificity, detection limit, quantitation limit, linearity, range, and robustness. The guidelines provide details on how to validate these parameters and determine method suitability.
The document summarizes the ICH Q2 R1 guideline on the validation of analytical procedures. It discusses the objective of validation, which is to demonstrate that an analytical procedure is suitable for its intended purpose. It describes the types of analytical procedures that should be validated, including identification tests, quantitative impurity tests, limit tests for impurities, and assay procedures. It then goes into detail describing the validation parameters that should be tested, including specificity, accuracy, precision, detection limit, quantitation limit, linearity, range, robustness, and system suitability. The document provides information on how to validate both compendial and non-compendial analytical procedures, as well as the concept of verification for compendial methods
Qualification of analytical instrumentsFaris ameen
This document provides guidelines for qualifying analytical instruments including electronic balances, pH meters, and UV-Visible spectrophotometers. It discusses the various levels of qualification including: Level I which involves selecting instruments and suppliers; Level II which involves installation and releasing instruments for use; Level III which involves periodic checks; and Level IV which involves in-use checks. Specific guidelines are provided for qualifying balances, pH meters, and UV-Visible spectrophotometers, including recommended tolerance limits for various parameters, calibration procedures, and qualification frequencies.
Analytical method development and validation for simultaneous estimationProfessor Beubenz
The document discusses analytical method development and validation for the simultaneous estimation of active pharmaceutical ingredients (APIs). It covers topics such as the need for method development, the steps involved, parameters for validation as outlined in ICH guidelines, and the use of high performance liquid chromatography (HPLC). The key objectives of validation are to demonstrate that the developed method is suitable for its intended purpose and can reliably quantify the APIs.
The document describes the development and validation of UV spectrophotometric methods for analyzing risperidone and lacosamide. It discusses selecting analytical wavelengths, developing standard curves, and validating the methods by determining accuracy, precision, specificity, linearity, range and other parameters as required by ICH guidelines. Validation results for the risperidone and lacosamide methods such as recovery percentages between 98.4-99.8%, precision of 0.67-0.50%, linear ranges of 2-6 μg/ml and 12-40 μg/ml respectively are also presented. The developed and validated methods provide accurate and precise quantification of active pharmaceutical ingredients and finished dosage forms using UV spectrophotometry.
Understanding of Analytical Method Validation Approach in Pharmaceutical Industry. Analytical method validation Verification is a wide chapter and a huge scope of applicability. In different types of methods, instrument, measurement approach all can effect the validation effort. However the basic fundamental will remains same, the parameters, acceptance criteria, functionality may vary depending upon the type of method, instrument etc.
This document provides qualification procedures for an electronic balance, pH meter, and UV-visible spectrophotometer. It describes design qualification, installation qualification, and operational qualification tests. For the electronic balance, design qualification includes supplier certification. Installation qualification includes installation and operational tests using reference weights. Operational qualification includes daily measurement of reference weights. For the pH meter and spectrophotometer, design qualification includes selection criteria. Installation qualification includes installation and checks. Operational qualification includes calibration and performance verification tests using standards traceable to national references.
This document provides information on calibrating and qualifying various analytical instruments. It discusses the importance of calibration and qualification to ensure proper functioning and accurate results. It describes the different types of qualification including design, installation, operational and performance qualification. It then provides details on specific calibration procedures for various instruments like electronic balances, pH meters, UV-Vis and IR spectrophotometers, and HPLC. The calibration procedures ensure the instruments meet parameters for accuracy, resolution, wavelength verification and flow rate consistency.
This document provides guidelines for validating bioanalytical methods used to measure drug concentrations in biological matrices. It defines key validation elements including selectivity, calibration curves, accuracy, precision, matrix effects, and stability testing. Guidelines are given for full validation of new methods as well as partial validation when modifying existing methods. Validation ensures reliable results for making critical decisions in drug development.
HPLC Method Development & Method Validation (mr.s)22suresh
This document describes the development and validation of an HPLC method for estimating drugs. It discusses the principles of HPLC, steps in method development including selecting the method, column, mobile phase and detector. Method validation parameters like accuracy, precision, specificity, linearity and robustness are also summarized. The document provides details on the optimization process and validation procedures to ensure the method is suitable for its intended use.
Calibration and validation of HPLC methods involves establishing that the instrument produces accurate and reproducible results. Key aspects include:
1. Calibration involves checking parameters like flow rate accuracy, wavelength accuracy, and detector linearity using reference standards.
2. Validation establishes method performance meets requirements. It involves determining accuracy over 3 concentration levels, precision through repeatability studies, and linearity through correlation coefficients.
3. Qualification includes design, installation, operational, and performance qualification to prove equipment works correctly and leads to expected results.
The document discusses pharmaceutical validation including definitions of qualification and validation. It provides details on types of qualification including design, installation, operational and performance qualification. Validation types such as prospective, concurrent and retrospective validation are summarized. The importance of validation master plan and validation protocols are highlighted. Key aspects of streamlining validation operations are also covered such as the importance of parallel development of API, analytical methods and drug product.
This document discusses guidelines for analytical method validation. It outlines the types of analytical methods that require validation including chromatographic, spectroscopic, and dissolution methods. It describes key performance characteristics that are evaluated in validation studies such as specificity, accuracy, precision, linearity, range, detection and quantitation limits, and robustness. The document provides details on how these characteristics are tested and the acceptance criteria used to ensure the method is suitable for its intended purpose. It also discusses circumstances under which revalidation may be necessary.
ANALYTICAL METHOD VALIDATION BY P.RAVISANKAR Dr. Ravi Sankar
This document discusses analytical method validation. It begins with an introduction that defines validation and discusses its importance and regulatory requirements. The document then covers specific validation parameters such as specificity, linearity, accuracy, precision, limit of detection, limit of quantification and more. For each parameter, the document provides definitions, procedures for evaluation, and acceptance criteria. It emphasizes that validation demonstrates a method is suitable for its intended purpose and supports the identity, quality, purity and potency of drug substances and products. The overall summary is that analytical method validation is critical to ensure quality and compliance in the pharmaceutical industry.
This document provides guidance on validation of analytical procedures for pharmaceutical products. It discusses key validation characteristics that should be considered for different types of analytical procedures, including identification tests, assays, and tests for impurities. The document defines important terms and recommends the validation characteristics that should typically be evaluated for each type of analytical procedure. It also provides recommendations on experimental approaches and data to collect in order to validate characteristics like specificity, linearity, range, accuracy, and precision of analytical procedures. The overall goal of validation is to demonstrate that an analytical procedure is suitable for its intended purpose.
Analytical methods validation as per ich & uspGANESH NIGADE
This document discusses analytical method validation as per ICH and USP guidelines. It defines validation as establishing documentary evidence that a procedure maintains compliance. Method validation involves demonstrating that an analytical procedure is suitable for its intended purpose by testing parameters such as accuracy, precision, specificity, detection limit, quantitation limit, linearity, range, ruggedness and robustness. It also discusses the different types of analytical procedures that require validation including identification tests, quantitative impurity tests, limit tests and assays.
analytical method validation and validation of hplcvenkatesh thota
The document summarizes a seminar on analytical method validation and validation of HPLC. It discusses parameters for method validation according to USP, BP, and ICH guidelines such as accuracy, precision, linearity, range, specificity, detection limit, and quantitation limit. It also covers validation of typical HPLC systems through qualification, design, installation, operational, and performance qualification. Key parameters evaluated during HPLC method validation are discussed, including system suitability tests involving retention factor, relative retention, theoretical plates, resolution, and tailing factor.
This document discusses validation and calibration of HPLC systems. It defines validation as establishing that an analytical procedure meets requirements for its intended use through laboratory studies. A validation protocol outlines how validation will be conducted. Equipment validation demonstrates that equipment is suitable for use and comparable to routine equipment. Calibration involves demonstrating that an instrument produces results within specified limits compared to a reference standard. The document outlines parameters to validate like accuracy, precision, specificity, range, robustness and more. It provides details on testing these parameters and accepting calibration of modules like the pump, injector, detector and column heating.
University Institute of Pharmaceutical Sciences is a flag bearer of excellence in Pharmaceutical education and research in the country. Here is another initiative to make study material available to everyone worldwide. Based on the new PCI guidelines and syllabus here we have a presentation dealing with qualifications of HPLC which is the " High Performance Liquid Chromatography".
Thank you for reading.
Hope it was of help to you.
UIPS,PU team
This document discusses the key aspects of analytical method validation including specificity, linearity, range, accuracy, precision, detection limit, quantitation limit, robustness, and system suitability testing. It provides detailed descriptions and recommendations for establishing each validation characteristic to demonstrate that an analytical procedure is suitable for its intended use.
This document outlines guidelines for analytical method validation as described in ICH Q2. It defines validation as establishing evidence that a method is suitable for its intended purpose. Key parameters that must be validated include accuracy, precision, specificity, detection limit, quantitation limit, linearity, range, and robustness. The guidelines provide details on how to validate these parameters and determine method suitability.
The document summarizes the ICH Q2 R1 guideline on the validation of analytical procedures. It discusses the objective of validation, which is to demonstrate that an analytical procedure is suitable for its intended purpose. It describes the types of analytical procedures that should be validated, including identification tests, quantitative impurity tests, limit tests for impurities, and assay procedures. It then goes into detail describing the validation parameters that should be tested, including specificity, accuracy, precision, detection limit, quantitation limit, linearity, range, robustness, and system suitability. The document provides information on how to validate both compendial and non-compendial analytical procedures, as well as the concept of verification for compendial methods
Qualification of analytical instrumentsFaris ameen
This document provides guidelines for qualifying analytical instruments including electronic balances, pH meters, and UV-Visible spectrophotometers. It discusses the various levels of qualification including: Level I which involves selecting instruments and suppliers; Level II which involves installation and releasing instruments for use; Level III which involves periodic checks; and Level IV which involves in-use checks. Specific guidelines are provided for qualifying balances, pH meters, and UV-Visible spectrophotometers, including recommended tolerance limits for various parameters, calibration procedures, and qualification frequencies.
Analytical method development and validation for simultaneous estimationProfessor Beubenz
The document discusses analytical method development and validation for the simultaneous estimation of active pharmaceutical ingredients (APIs). It covers topics such as the need for method development, the steps involved, parameters for validation as outlined in ICH guidelines, and the use of high performance liquid chromatography (HPLC). The key objectives of validation are to demonstrate that the developed method is suitable for its intended purpose and can reliably quantify the APIs.
The document describes the development and validation of UV spectrophotometric methods for analyzing risperidone and lacosamide. It discusses selecting analytical wavelengths, developing standard curves, and validating the methods by determining accuracy, precision, specificity, linearity, range and other parameters as required by ICH guidelines. Validation results for the risperidone and lacosamide methods such as recovery percentages between 98.4-99.8%, precision of 0.67-0.50%, linear ranges of 2-6 μg/ml and 12-40 μg/ml respectively are also presented. The developed and validated methods provide accurate and precise quantification of active pharmaceutical ingredients and finished dosage forms using UV spectrophotometry.
Understanding of Analytical Method Validation Approach in Pharmaceutical Industry. Analytical method validation Verification is a wide chapter and a huge scope of applicability. In different types of methods, instrument, measurement approach all can effect the validation effort. However the basic fundamental will remains same, the parameters, acceptance criteria, functionality may vary depending upon the type of method, instrument etc.
This document provides qualification procedures for an electronic balance, pH meter, and UV-visible spectrophotometer. It describes design qualification, installation qualification, and operational qualification tests. For the electronic balance, design qualification includes supplier certification. Installation qualification includes installation and operational tests using reference weights. Operational qualification includes daily measurement of reference weights. For the pH meter and spectrophotometer, design qualification includes selection criteria. Installation qualification includes installation and checks. Operational qualification includes calibration and performance verification tests using standards traceable to national references.
This document provides information on calibrating and qualifying various analytical instruments. It discusses the importance of calibration and qualification to ensure proper functioning and accurate results. It describes the different types of qualification including design, installation, operational and performance qualification. It then provides details on specific calibration procedures for various instruments like electronic balances, pH meters, UV-Vis and IR spectrophotometers, and HPLC. The calibration procedures ensure the instruments meet parameters for accuracy, resolution, wavelength verification and flow rate consistency.
This document provides guidelines for validating bioanalytical methods used to measure drug concentrations in biological matrices. It defines key validation elements including selectivity, calibration curves, accuracy, precision, matrix effects, and stability testing. Guidelines are given for full validation of new methods as well as partial validation when modifying existing methods. Validation ensures reliable results for making critical decisions in drug development.
HPLC Method Development & Method Validation (mr.s)22suresh
This document describes the development and validation of an HPLC method for estimating drugs. It discusses the principles of HPLC, steps in method development including selecting the method, column, mobile phase and detector. Method validation parameters like accuracy, precision, specificity, linearity and robustness are also summarized. The document provides details on the optimization process and validation procedures to ensure the method is suitable for its intended use.
Calibration and validation of HPLC methods involves establishing that the instrument produces accurate and reproducible results. Key aspects include:
1. Calibration involves checking parameters like flow rate accuracy, wavelength accuracy, and detector linearity using reference standards.
2. Validation establishes method performance meets requirements. It involves determining accuracy over 3 concentration levels, precision through repeatability studies, and linearity through correlation coefficients.
3. Qualification includes design, installation, operational, and performance qualification to prove equipment works correctly and leads to expected results.
The document discusses pharmaceutical validation including definitions of qualification and validation. It provides details on types of qualification including design, installation, operational and performance qualification. Validation types such as prospective, concurrent and retrospective validation are summarized. The importance of validation master plan and validation protocols are highlighted. Key aspects of streamlining validation operations are also covered such as the importance of parallel development of API, analytical methods and drug product.
This document discusses guidelines for analytical method validation. It outlines the types of analytical methods that require validation including chromatographic, spectroscopic, and dissolution methods. It describes key performance characteristics that are evaluated in validation studies such as specificity, accuracy, precision, linearity, range, detection and quantitation limits, and robustness. The document provides details on how these characteristics are tested and the acceptance criteria used to ensure the method is suitable for its intended purpose. It also discusses circumstances under which revalidation may be necessary.
ANALYTICAL METHOD VALIDATION BY P.RAVISANKAR Dr. Ravi Sankar
This document discusses analytical method validation. It begins with an introduction that defines validation and discusses its importance and regulatory requirements. The document then covers specific validation parameters such as specificity, linearity, accuracy, precision, limit of detection, limit of quantification and more. For each parameter, the document provides definitions, procedures for evaluation, and acceptance criteria. It emphasizes that validation demonstrates a method is suitable for its intended purpose and supports the identity, quality, purity and potency of drug substances and products. The overall summary is that analytical method validation is critical to ensure quality and compliance in the pharmaceutical industry.
This document provides guidance on validation of analytical procedures for pharmaceutical products. It discusses key validation characteristics that should be considered for different types of analytical procedures, including identification tests, assays, and tests for impurities. The document defines important terms and recommends the validation characteristics that should typically be evaluated for each type of analytical procedure. It also provides recommendations on experimental approaches and data to collect in order to validate characteristics like specificity, linearity, range, accuracy, and precision of analytical procedures. The overall goal of validation is to demonstrate that an analytical procedure is suitable for its intended purpose.
This document provides information on cleaning validation and analytical method validation. It discusses key aspects of cleaning validation including protocols, sampling methods, acceptance criteria, and reports. It emphasizes that cleaning validation is important to prevent contamination between products manufactured using the same equipment. It also covers parameters that are important to validate analytical methods such as selectivity, precision, accuracy, linearity, and calibration curves. The document is a reference for professionals on best practices for cleaning validation and analytical method validation.
The document discusses several regulatory agencies that oversee medicines and medical devices. The United States Food and Drug Administration (USFDA) regulates food, drugs, cosmetics, and medical devices in the US. The Medicines and Healthcare products Regulatory Agency (MHRA) regulates medicines and medical devices in the UK. The Central Drugs Standard Control Organization (CDSCO) regulates drugs and cosmetics in India under the Ministry of Health and Family Welfare. Each agency is responsible for ensuring the safety and efficacy of products under its purview.
Overview of analytical method validationprarkash_dra
This document provides an overview of analytical method validation in the pharmaceutical industry. It discusses key aspects of method validation including specificity, linearity, range, detection limit, quantitation limit, accuracy, and precision. Validation is important to demonstrate that an analytical method is suitable for its intended use in accurately measuring the quality of pharmaceutical products. The document outlines recommended approaches for establishing performance characteristics during the validation process.
The Therapeutic Goods Administration or TGA is the regulatory body for therapeutic goods in Australia.
The TGA is responsible for conducting assessment and monitoring activities to ensure that therapeutic goods available in Australia are of an acceptable standard.
This document discusses guidelines for analytical method validation. It outlines types of analytical methods that require validation including chromatographic, spectroscopic, and dissolution methods. Key analytical performance characteristics used in validation are described such as specificity, linearity, range, accuracy, precision, detection/quantitation limits, robustness, and system suitability testing. The document provides details on determining these characteristics and validating methods. It also addresses revalidation and references for further information.
This document discusses analytical method validation. It provides definitions and guidelines for validating analytical methods from regulatory agencies. Key aspects of method validation discussed include accuracy, precision, specificity, range, linearity, limits of detection and quantification. Validation parameters are described for different types of analytical tests including identification, quantitative impurity tests and assays. Guidelines are provided for qualifying analytical instrumentation and categorizing instruments based on complexity.
The document discusses various validation methods including validation of equipment, analytical instruments, and analytical methods. It provides details on calibration, analytical method validation parameters like accuracy, precision, specificity, linearity, range, limits of detection and quantitation. It also discusses process validation types like prospective, concurrent and retrospective validation as well as cleaning validation and equipment validation.
validation of analytical procedure USFDA GuidlineArchana Chavhan
The document discusses the validation of analytical procedures as outlined by regulatory agencies like the USFDA. It defines key terms like accuracy, precision, specificity, detection limit, quantitation limit, linearity, range, and robustness. For each term, it provides the definition and recommendations on how to determine the characteristic during the validation process, such as testing a minimum number of samples over a specified range and concentration levels. The overall purpose of the validation is to establish that the analytical procedure is suitable for its intended use.
The document provides guidelines on validation of analytical procedures from the International Conference on Harmonisation (ICH) and the World Health Organization (WHO). It discusses validation characteristics like accuracy, precision, specificity, linearity, range, detection limit and quantitation limit that should be considered when validating identification tests, assays, and tests for impurities. It provides definitions for key terms and recommendations on how validation of these characteristics should be performed.
Ich guidelines on validation for analytical method/equipmentssakshi singh
The ICH guidelines provide validation requirements for analytical procedures including accuracy, precision, specificity, linearity, range, limit of detection, and limit of quantification. Accuracy and precision should be established across the specified range and determined using multiple concentration levels in triplicate. Precision has three levels - repeatability under short-term conditions, intermediate precision over longer time periods and varied conditions, and reproducibility between laboratories. The limits of detection and quantification establish the lowest levels that can be detected and quantified. Linearity is evaluated across several concentration levels and statistical measures. The range demonstrates performance within the intended concentrations. Specificity ensures no interference from impurities or matrix.
The document discusses validation of analytical procedures. Validation is required to confirm a procedure is suitable for its intended use. It identifies potential errors and determines if the method is acceptable. Key validation characteristics discussed include specificity, linearity, range, accuracy, precision, limit of detection, limit of quantitation, robustness, and system suitability. The document provides details on how to evaluate each characteristic.
The document discusses analytical method validation which is required by pharmaceutical GMPs. It defines analytical method validation as establishing that a method's performance characteristics meet requirements for its intended purpose through laboratory studies. The key steps of validation include specificity, linearity, accuracy, precision, range, detection/quantitation limits, and robustness. Validation ensures testing methods are suitable and reliable for their intended use in pharmaceutical quality control.
Method validation is the process of documenting / proving that an analytical method provides analytical data acceptable for the intended use. A pharmaceutical drug product must meet all its specifications throughout its entire shelf-life. The performance of product characteristics throughout the shelf-life must be tested by analytical method for the product’s chemical, physiochemical, microbiological and biological characteristics. The method of analysis used must be validated. This is required to ensure the product’s safety and efficacy throughout all phases of its shelf-life. Validation is the process of establishing documentary evidence demonstrating that a procedure, process, or activity carried out in testing and then production maintains the desired level of compliance at all stages.
The document discusses validation criteria for analytical test procedures, including specificity, linearity and range, accuracy, precision (repeatability, intermediate precision), detection limit, and quantitation limit. It provides definitions and recommendations for establishing each criterion through studies involving spiked samples, calibration standards, and statistical analysis of results. Criteria validation helps demonstrate that an analytical procedure is suitable for its intended purpose of identifying, quantifying, or limiting substances within drug samples.
This document summarizes guidelines for analytical method validation from various regulatory agencies. It discusses the purpose of validation to verify method suitability. Key analytical performance characteristics covered include specificity, linearity, range, accuracy, precision, detection/quantitation limits, robustness, and system suitability testing. It notes that revalidation may be necessary if the analytical method or drug product is changed.
This document summarizes guidelines for analytical method validation from various regulatory agencies. It discusses the purpose of validation to verify method suitability for submissions. Key validation characteristics covered include specificity, linearity, range, accuracy, precision, detection/quantitation limits, robustness, and system suitability testing. It notes that revalidation may be necessary if the analytical method or drug product is changed.
This document provides guidance on bioanalytical method validation. It discusses validation parameters such as selectivity, accuracy, precision, recovery, calibration curves, and stability. Full validation is recommended when developing a new bioanalytical method or validating a revised method. Partial validation may be done for modifications like changes in matrix, reagents, or instrumentation. Cross-validation between methods and labs is also addressed. Recommendations are provided for chemical and microbiological/ligand-binding assay validation.
This document discusses validation of analytical procedures. It is divided into two parts. Part I provides definitions and discusses typical validation characteristics such as accuracy, precision, specificity, detection limit, and quantitation limit. Part II provides more detailed methodology guidance on how to validate these characteristics. It describes how to validate specificity, accuracy, precision, detection limit, quantitation limit, linearity, range, and robustness of analytical procedures. The goal of validation is to demonstrate that analytical procedures are suitable for their intended purpose in identifying, quantifying, and testing impurities in drug substances and products.
International conference on harmonisation validation of analytical proceduresnoushin javidvand
This document provides guidance on validating analytical procedures according to the International Conference on Harmonization. It defines key terms and outlines the validation characteristics that should be evaluated for identification tests, assays for active ingredients or impurities. These include accuracy, precision, repeatability, specificity, detection limit, quantitation limit, linearity, range, and robustness. The document provides detailed methodology for testing each validation characteristic on analytical procedures to demonstrate the procedure is suitable for its intended use.
General Principles of Analytical Method of Validation.pdfTamannaKumari8
Validation is the process of establishing documentary evidence demonstrating that a procedure, process, activity carried out in
testing and then production maintain the desirable level of compliance all stages.
The process of providing the analytical procedure is acceptable or its intended us.(ICH Q
This document provides an overview of analytical method validation. It defines validation as proving a method leads to expected results. Validation is required for analytical tests, equipment, and processes. Once validated, a method is expected to remain in control if unchanged. The document discusses types of analytical procedures that must be validated, including identification, quantitative impurity, limit tests, and assays. It also distinguishes between validation and verification. Key aspects of validation covered include system suitability, specificity, linearity, range, precision, accuracy, recovery, and robustness. The validation characteristics and acceptance criteria are defined.
This document outlines USFDA guidelines for bioanalytical method validation. It discusses the objectives of method development which are to accurately and precisely quantify analytes under given laboratory conditions. The steps in method development include literature review, technique identification and optimization, reference standard preparation, and more. It also describes the types of validation including full, partial, and cross validation. The key validation parameters that must be evaluated and criteria that must be met are selectivity, accuracy, precision, recovery, calibration curves, sensitivity, reproducibility, and stability.
This document discusses various concepts related to analytical method validation including accuracy, precision, specificity, detection limit, and quantitation limit. It provides definitions and recommendations for determining each concept. For accuracy, it recommends assessing using spiked samples or an independent procedure and reporting as percent recovery. For precision, it recommends determining repeatability using 9 determinations at 3 concentrations and reporting as standard deviation and coefficient of variation. Detection limit can be determined visually, by signal-to-noise ratio, or by standard deviation of the blank. Quantitation limit is the lowest concentration that can be quantified and can also be determined visually or by signal-to-noise ratio.
This document discusses analytical method validation. It provides guidance on validation from various organizations. It describes the types of analytical procedures that require validation including chromatographic, spectroscopic, and dissolution methods. Key validation characteristics that should be considered include specificity, linearity, range, accuracy, precision, detection limit, quantitation limit, robustness, and system suitability. The document provides details on how these characteristics should be determined during the validation process. It also discusses circumstances under which revalidation may be necessary such as changes to the drug synthesis or analytical method.
Validation is defined as establishing documented evidence that a process will consistently produce a product meeting specifications. Analytical methods must be validated for identification tests, quantitative tests for impurities, limit tests, and assays. Key parameters for validation include linearity and range, specificity, precision, accuracy, limits of detection and quantification, robustness, and system suitability. Validation demonstrates a method is suitable for its intended use by proving the method is accurate, precise, specific, robust, and capable of detecting analytes at low concentrations.
This document discusses RNA molecule structure prediction and the assumptions made, including that the most likely structure is similar to the most stable energetically, and that the energy of any position is only influenced by local sequence and structure. It also mentions complementary interactions of secondary structures and circle plots of base pairs.
This document discusses several topics related to proteins including the titration curve of glycine, CLUSTALW scoring scheme for protein sequence alignment, formation of peptide bonds, structural hierarchy of proteins, protein sequencing, alpha-helix and beta conformations, and hydropathy plots for analyzing protein sequences.
This document discusses the primary, secondary, tertiary, and quaternary structure of proteins. It begins by describing the important biological functions of proteins and the general structures of globular and fibrous proteins. It then discusses the structures of amino acids and how peptide bonds link amino acids into polypeptide chains. The levels of protein structure are introduced, including the alpha helix and beta sheet secondary structures, tertiary folding of polypeptide chains, and arrangement of subunits in quaternary structure. Common protein domains and motifs are also illustrated.
This document discusses protein structure, classification, prediction, and visualization. It covers secondary structure elements like alpha helices and beta sheets, as well as tertiary and quaternary structure. It describes protein structure databases like the Protein Data Bank and tools for visualizing protein structures. Different amino acid properties that influence secondary structure are also discussed.
This document provides information on various computational tools and methods for protein identification, characterization, and structure prediction. It discusses tools that use amino acid composition, sequence alignment, peptide mass fingerprinting, and physico-chemical properties to identify proteins. It also describes methods such as Chou-Fasman, GOR, and neural networks that predict protein secondary structure and properties based on amino acid order, propensities, and probabilities.
Structurally variable regions like loops, insertions and deletions can complicate protein structure modeling. The structure of an equivalent length segment from a homologous protein provides a guide for modeling missing regions, though the chosen segment may not always fit properly. De novo prediction involves using rotamer libraries of common amino acid conformations to predict side chain positions. Model validation checks the stereochemical accuracy, packing quality, and folding reliability of the predicted structure.
This document discusses important parameters for designing successful PCR primers. Key factors include primer length, melting temperature (Tm), specificity, and GC content. Primer length determines specificity, annealing temperature and time. For primers between 18-24 bases targeting a 50°C annealing temperature, the calculated Tm should be around 55°C. Both primers should have similar Tms. Other considerations include avoiding intra-primer complementarity beyond 3 base pairs and maintaining a GC content between 45-55%.
This document discusses phylogenetic studies and the construction of phylogenetic trees. It notes that fossil records are unreliable, so phylogenetic trees are primarily based on molecular sequencing data and morphological data. There are several assumptions made in phylogenetic analysis, including that sequences are homologous, phylogenetic divergence is bifurcating, and each position in a sequence evolved independently. The document outlines different types of phylogenetic trees, steps in phylogenetic analysis like choosing molecular markers and tree building methods, and criteria for assessing the reliability of phylogenetic trees.
Multiple sequence alignment is used to determine evolutionary relationships and structural relationships between sequences. It provides information on the most similar regions between sequences and can predict specific probes. Multiple sequence alignment extends pairwise sequence alignment through dynamic programming to align three or more sequences simultaneously. Popular multiple sequence alignment programs like CLUSTALW use progressive alignment methods that first align closely related sequences, then progressively align more distantly related sequences.
Homology modeling is a technique used to generate a three-dimensional structural model of a protein from its amino acid sequence. Modeller is a popular software program used for homology modeling that automates model building from a sequence-structure alignment using a known protein structure as a template. Homology modeling is useful for predicting protein structure and function when experimental structures are not available.
Homology modeling is a technique used to predict the 3D structure of a protein based on the alignment of its amino acid sequence to known protein structures. It relies on the observation that structure is more conserved than sequence during evolution. The key steps in homology modeling include: 1) identifying a template structure through sequence alignment tools like BLAST, 2) correcting any errors in the initial alignment, 3) generating the protein backbone based on the template structure, 4) modeling any loops or missing regions, 5) adding side chains, 6) optimizing the model structure energetically, and 7) validating that the final model matches the template structure and has correct stereochemistry. Homology modeling is useful for applications like structure-based drug design
This document discusses different methods for genome sequencing and assembly, including restriction enzyme fingerprinting, marker sequences, and hybridization assays. It focuses on using marker sequences like sequence-tagged sites (STS), expressed sequence tags (ESTs), untranslated regions (UTRs), and single nucleotide polymorphisms (SNPs) to map genomes. Large-insert cloning vectors like BACs and PACs can be used with restriction enzyme fingerprinting and FPC software to assemble contigs and map genomes at a large scale. Marker sequences provide a dense set of physical markers to build accurate physical maps of genomes.
This document discusses gene identification and genome annotation. It describes how gene finding in eukaryotes is difficult due to smaller percentages of genes in genomes like humans, and larger intron sizes. It covers open reading frames, complications with introns, and the use of six-frame translation to find protein coding sequences. Software tools for structural and functional annotation are outlined, including identifying genes through homology searching and ab initio prediction using hidden Markov models. The accuracy challenges of ab initio prediction are also summarized.
This document discusses genome analysis and sequencing. It provides background on identifying genes and studying disease processes through genome sequencing. It also describes goals of identifying gene function through experiments and challenges like gene prediction and repetitive sequences. Specific projects aimed at tracking human genetic variations and the first bacterial genome sequencing are summarized. Criteria for selecting early genomes to sequence are outlined. Key differences between prokaryotic and eukaryotic genomes are noted, including the presence of chromosomes, repeats, introns and heterochromatin/euchromatin. Different types of repetitive sequences like satellites, minisatellites and microsatellites are defined. Transposable elements in eukaryotes are also briefly introduced.
FASTA is a program for rapidly aligning protein and DNA sequences. It searches for matching k-tuples or sequence words and builds a local alignment based on these matches. It identifies the 10 best matching regions through k-tuple screening, joins nearby matches, and finds the highest density regions. It generates longer regions of identity and recalculates scores, with INITN and OPT scores used to rank database matches. Sensitivity refers to the ability to locate distantly related family members with limited similarity.
Drug design involves inventing new pharmaceutical drugs based on knowledge of biological targets, with classes of medications defined by their chemical properties, routes of administration, effects on biological systems, and therapeutic effects. The Anatomical Therapeutic Chemical classification system categorizes drugs into groups such as antipyretics, analgesics, antimalarial drugs, antibiotics, and antiseptics based on their medical use. Strategies for drug design include ligand-based and structure-based approaches.
Molecular descriptors are numerical values that characterize molecular properties and structures. They can represent physicochemical properties or values derived from algorithmic techniques applied to molecular structures. Descriptors vary in complexity and computational requirements. Some are based on experimental data while others are algorithmic constructs. Two-dimensional (2D) descriptors are calculated from 2D structures and include counts, physicochemical properties, and topological indices. Three-dimensional (3D) descriptors encode spatial relationships and include fragment screens and pharmacophore keys.
Biological data is widely distributed over the web and can be retrieved using search engines like Google or data retrieval tools. Dedicated data retrieval tools for molecular biologists include Entrez, DBGET, and SRS which allow text searching of linked databases and sequence searching. Entrez, developed by NCBI, integrates information from databases including GenBank, PubMed, and OMIM. DBGET covers databases like GenBank, EMBL, and PDB. SRS, developed by EBI, integrates over 80 molecular biology databases.
BLAST is a program that compares nucleotide or protein sequences to sequence databases and calculates the statistical significance of matches. It performs sequence similarity searches using either FASTA or BLAST algorithms. The BLAST process involves filtering sequences, preparing a list of words, evaluating matches using BLOSUM62, organizing high-scoring words into a search tree, scanning databases for matches, extending alignments, identifying statistically significant matches, and calculating expect values for alignments.
This document provides information about several nucleotide and protein sequence databases including:
- INSDC (International Nucleotide Sequence Database Collaboration) which includes GenBank, EMBL, and DDBJ.
- GenBank which contains over 80 billion nucleotide bases from 76 million sequences and doubles in size every 18 months. The top species represented are human, mouse, rat, cattle, and maize.
- EMBL and DDBJ which are similar to GenBank in content and format but maintained by different collaborations. Secondary databases like UniProt, PROSITE and PRINTS/BLOCKS provide additional annotation and analysis of sequences.
2. INTRODUCTION
• This document presents a discussion of the
characteristics for consideration during the
validation of the analytical procedures included
as part of registration applications of a
respective regulatory bodies.
• The objective of validation of an analytical
procedure is to demonstrate that it is suitable
for its intended purpose.
• The characteristics applicable to identification,
control of impurities and assay procedures is
included. Other analytical procedures may be
considered in future additions to this document.
3. Types of Analytical Procedures to
be Validated
• Validation of analytical procedures is
directed to the four most common
types of analytical procedures:
• Identification tests;
• Quantitative tests for impurities' content;
• Limit tests for the control of impurities;
• Quantitative tests of the active moiety in
samples of drug substance or drug product
or other selected component(s) in the drug
product.
4. - Identification tests are intended to ensure the
identity of an analyte in a sample. This is
normally achieved by comparison of a
property of the sample (e.g., spectrum,
chromatographic behavior, chemical
reactivity, etc) to that of a reference
standard;
- Testing for impurities can be either a
quantitative test or a limit test for the
impurity in a sample. Either test is intended
to accurately reflect the purity
characteristics of the sample. Different
validation characteristics are required for a
quantitative test than for a limit test;
5. • Assay procedures are intended to
measure the analyte present in a given
sample. The assay represents a
quantitative measurement of the major
component(s) in the drug substance.
For the drug product, similar validation
characteristics also apply when
assaying for the active or other
selected component(s). The same
validation characteristics may also
apply to assays associated with other
analytical procedures (e.g.,
dissolution).
6. • The objective of the analytical procedure
should be clearly understood since this will
govern the validation characteristics which
need to be evaluated. Typical validation
characteristics which should be considered
are listed below;
• Accuracy
• Precision
− Repeatability
− Intermediate Precision
• Specificity
• Detection Limit
• Quantitation Limit
• Linearity
• Range
7. • Furthermore revalidation may be
necessary in the following
circumstances;
• changes in the synthesis of the drug
substance;
• changes in the composition of the finished
product;
• changes in the analytical procedure.
• The degree of revalidation required depends
on the nature of the changes. Certain other
changes may require validation as well.
8. SPECIFICITY
• Specificity is the ability to assess unequivocally the
analyte in the presence of components which may be
expected to be present. Typically these might include
impurities, degradants, matrix, etc.
• Lack of specificity of an individual analytical procedure
may be compensated by other supporting analytical
procedure(s).
• This definition has the following implications:
• Identification: to ensure the identity of an analyte.
• Purity Tests: to ensure that all the analytical
procedures performed allow an accurate statement of
the content of impurities of an analyte, i.e. related
substances test, heavy metals, residual solvents
content, etc.
• Assay (content or potency): to provide an exact
result which allows an accurate statement on the
content or potency of the analyte in a sample.
9. ACCURACY
• The accuracy of an analytical procedure
expresses the closeness of agreement
between the value which is accepted
either as a conventional true value or an
accepted reference value and the value
found.
• This is sometimes termed trueness.
10. PRECISION
• The precision of an analytical procedure expresses the
closeness of agreement (degree of scatter) between a
series of measurements obtained from multiple
sampling of the same homogeneous sample under the
prescribed conditions.
• Precision may be considered at three levels:
repeatability, intermediate precision and
reproducibility.
• Precision should be investigated using homogeneous,
authentic samples.
• The precision of an analytical procedure is usually
expressed as the variance, standard deviation or
coefficient of variation of a series of measurements.
11. • Repeatability
Repeatability expresses the precision under
the same operating conditions over a short
interval of time. Repeatability is also termed
intra-assay precision .
• Intermediate precision
Intermediate precision expresses within-laboratories
variations: different days,
different analysts, different equipment, etc.
• Reproducibility
Reproducibility expresses the precision
between laboratories (collaborative studies,
usually applied to standardization of
methodology).
12. DETECTION LIMIT
The detection limit of an individual analytical
procedure is the lowest amount of analyte in a
sample which can be detected but not
necessarily quantitated as an exact value.
13. QUANTITATION LIMIT
The quantitation limit of an individual
analytical procedure is the lowest amount
of analyte in a sample which can be
quantitatively determined with suitable
precision and accuracy. The quantitation
limit is a parameter of quantitative assays
for low levels of compounds in sample
matrices, and is used particularly for the
determination of impurities and/or
degradation products.
14. LINEARITY
The linearity of an analytical procedure is its
ability (within a given range) to obtain test
results which are directly proportional to the
concentration (amount) of analyte in the
sample.
RANGE
The range of an analytical procedure is the
interval between the upper and lower
concentration (amounts) of analyte in the
sample (including these concentrations) for
which it has been demonstrated that the
analytical procedure has a suitable level of
precision, accuracy and linearity.
15. ROBUSTNESS
The robustness of an analytical procedure is a
measure of its capacity to remain unaffected
by small, but deliberate variations in method
parameters and provides an indication of its
reliability during normal usage.
16. ANALYTICAL PROCEDURES
VALIDATION
METHODOLOGY
• Its purpose is to provide some guidance and
recommendations on how to consider the
various validation characteristics for each
analytical procedure. In some cases (for
example, demonstration of specificity), the
overall capabilities of a number of analytical
procedures in combination may be
investigated in order to ensure the quality of
the drug substance or drug product. In
addition, the document provides an indication
of the data which should be presented in a
registration application .
• All relevant data collected during validation
and formulae used for calculating validation
characteristics should be submitted and
discussed as appropriate.
17. SPECIFICITY
• An investigation of specificity should be conducted
during the validation of identification tests, the
determination of impurities and the assay.
• The procedures used to demonstrate specificity will
depend on the intended objective of the analytical
procedure.
• It is not always possible to demonstrate that an
analytical procedure is specific for a particular analyte
(complete discrimination). In this case a combination
of two or more analytical procedures is recommended
to achieve the necessary level of discrimination.
• Identification
• Assay and Impurity Test(s)
• Impurities are available
• Impurities are not available
18. LINEARITY
A linear relationship should be evaluated across the
range (see section 3) of the analytical procedure. It
may be demonstrated directly on the drug substance
(by dilution of a standard stock solution) and/or
separate weighings of synthetic mixtures of the drug
product components, using the proposed procedure.
Linearity should be evaluated by visual inspection of a
plot of signals as a function of analyte concentration
or content. If there is a linear relationship, test results
should be evaluated by appropriate statistical
methods, for example, by calculation of a regression
line by the method of least squares.
The correlation coefficient, y-intercept, slope of the
regression line and residual sum of squares should be
submitted.
For the establishment of linearity, a minimum of 5
concentrations is recommended. Other approaches
should be justified.
19. RANGE
• The specified range is normally derived from linearity studies
and depends on the intended application of the procedure. It
is established by confirming that the analytical procedure
provides an acceptable degree of linearity, accuracy and
precision when applied to samples containing amounts of
analyte within or at the extremes of the specified range of the
analytical procedure.
• The following minimum specified ranges should be
considered:
• - for the assay of a drug substance or a finished (drug)
product: normally from 80 to 120 percent of the test
concentration;
• - for content uniformity, covering a minimum of 70 to 130
percent of the test concentration, unless a wider more
appropriate range, based on the nature of the dosage form
(e.g., metered dose inhalers), is justified;
• for dissolution testing: +/-20 % over the specified range
20. ACCURACY
• Assay
• Drug Substance - application of an analytical
procedure to an analyte of known purity
• Drug Product - application of the analytical
procedure to synthetic mixtures of the drug
product components to which known quantities of
the drug substance.
- in cases where it is impossible to obtain samples of
all drug product components , it may be acceptable
either to add known quantities of the analyte to the
drug product or to compare the results obtained from
a second, well characterized procedure, the accuracy
of which is stated and/or defined.
• Impurities (Quantitation) - It should be clear
how the individual or total impurities are to be
determined e.g., weight/weight or area percent, in
all cases with respect to the major analyte.
• Recommended Data - Accuracy should be
assessed using a minimum of 9 determinations
over a minimum of 3 concentration levels covering
the specified range
21. PRECISION
• Repeatability - Repeatability should be
assessed using a minimum of 9
determinations covering the specified range
for the procedure and a minimum of 6
determinations at 100% of the test
concentration.
• Intermediate Precision - Typical
variations to be studied include days,
analysts, equipment, etc. It is not
considered necessary to study these effects
individually. The use of an experimental
design (matrix) is encouraged.
• Reproducibility - Reproducibility is
assessed by means of an inter-laboratory
trial.
22. DETECTION LIMIT
• Based on Visual Evaluation
• Based on Signal-to-Noise
• Based on the Standard Deviation of
the Response and the Slope
• Based on the Standard Deviation of
the Blank
• Based on the Calibration Curve
23. QUANTITATION LIMIT
• Based on Visual Evaluation
• Based on Signal-to-Noise
• Based on the Standard Deviation of
the Response and the Slope
• Based on the Standard Deviation of
the Blank
• Based on the Calibration Curve
24. ROBUSTNESS
• The evaluation of robustness should be considered during the
development phase and depends on the type of procedure
under study. It should show the reliability of an analysis with
respect to deliberate variations in method parameters.
• Examples of typical variations are:
- stability of analytical solutions;
- extraction time.
In the case of liquid chromatography, examples of typical
variations are:
- influence of variations of pH in a mobile phase;
- influence of variations in mobile phase composition;
- different columns (different lots and/or suppliers);
- temperature;
- flow rate.
In the case of gas-chromatography, examples of typical
variations are:
- different columns (different lots and/or suppliers);
- temperature;
- flow rate.
25. SYSTEM SUITABILITY TESTING
• System suitability testing is an integral
part of many analytical procedures.
• The tests are based on the concept that
the equipment, electronics, analytical
operations and samples to be analyzed
constitute an integral system that can be
evaluated as such.
• System suitability test parameters to be
established for a particular procedure
depend on the type of procedure being
validated.